ATHN Board of Directors

Our Board of Directors is made up of ATHN Affiliates, management, and consumers, as well as liaisons from the Centers for Disease Control and Prevention (CDC) Division of Blood Disorders, the National Heart, Lung and Blood Institute (NHLBI), and the Health Resources and Services Administration (HRSA) Maternal and Child Health Bureau (MCHB). We are infinitely grateful for their continued dedication and professional guidance.

2018 Board Members

Ellis J. Neufeld, MD, PhD

Chair, ATHN Board of Directors
Clinical Director, Physician-in-Chief, and
Executive Vice President
St. Jude Children's Research Hospital
Memphis, TN

Janna M. Journeycake, MD, MSCS

Chair-elect, ATHN Board of Directors
Assistant Professor, CCBD
North Texas Hemophilia and Thrombosis Program-Pediatric Program /
Center for Cancer & Blood Disorders
Children's Medical Center, Hematology/Oncology
Dallas, TX

Sarah O'Brien, MD

Secretary, ATHN Board of Directors
Nationwide Children's Hospital Hemostasis and Thrombosis Center
Associate Professor of Pediatrics
Ohio State University College of Medicine
Columbus, OH

Tamara Vogel, MBA

Treasurer, ATHN Board of Directors
Administrator
The Institute on Development and Disability
Oregon Health and Science University
Portland, OR

Michael Recht, MD, PhD

Immediate Past Chair, ATHN Board of Directors
Professor of Pediatrics and Medicine
Director, The Hemophilia Center
Oregon Health & Science University
Portland, OR

Shannon Carpenter, MD, MS

Professor of Pediatrics
UMKC School of Medicine, Hematology/Oncology
Director, Kansas City Regional Hemophilia Treatment Center
Director, Anticoagulation Management Program
Children's Mercy Hospital
Kansas City, MO

Jeff Cornett

Vice President of Research & Public Policy
Hemophilia of Georgia, Inc.
Atlanta, GA

Stacy E. Croteau, MD, MMS

Attending Hematologist, Boston Children's Hospital
Associate Director, Boston Hemophilia Center
Assistant Professor of Pediatrics, Harvard Medical School
Boston, MA

Jim Munn, RN, MS

Program and Nurse Coordinator
University of Michigan Hemophilia and Coagulation Disorders
Ann Arbor, MI

Brenda Riske, MS, MBA, MPA

Director
Brenda Riske Consulting
Denver, CO

Robert Sidonio, MD

Emory/CHOA Comprehensive Hemophilia Program
Atlanta, GA

Mark W. Skinner, JD

President, Board of Directors, World Federation of Hemophilia USA
President and CEO, Institute for Policy Advancement, Ltd.
Washington, DC

Christopher E. Walsh, MD, PhD

Associate Professor Medicine, Hematology and Medical Oncology
Mount Sinai School of Medicine
Regional Director, Region II
New York, NY

Vanessa Byams, MPH

CDC Liaison (non-voting liaison)
Health Scientist
Division of Blood Disorders
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention
Atlanta, GA

W. Keith Hoots, MD

Liaison, NHLBI (non-voting liaison)
Division Director
DHHS/NIH/N

Kathryn McLaughlin, MPH

MCHB Liaison (non-voting liaison)
Program Officer, National Hemophilia Program
MCHB/DSCSHN/Genetic Services Branch
Rockville, MD

Steven Pipe, MD

MASAC Liaison (non-voting member)
Associate Professor of Pediatrics and Pathology
Laurence A. Boxer Research Professor of Pediatrics and Communicable Diseases
Director, Div. of Pediatric Hematology and Oncology
Pediatric Medical Director, Hemophilia and Coagulation Disorders Program
Director, Special Coagulation Laboratory
Director, Fellowship Program in Pediatric Hematology and Oncology
Ann Arbor, MI

Crystal Watson

President and CEO
American Thrombosis and Hemostasis Network
Rochester, NY